Skip to main content

Nasdaq IPOs

Danish rare disease biotech Orphazyme prices US IPO at $11

6 years ago
Orphazyme, a Danish late-stage biotech developing protein therapies for rare neurodegenerative diseases, raised $84 million by offering 7.6 million ADS equivalents at $11, below the as-converted last close of its shares on the Nasdaq Copenhagen (ORPHA). At pricing, the company ra
Renaissance Capital

TMT SPAC Spartacus Acquisition files for a $250 million IPO

6 years ago
Spartacus Acquisition, a blank check company targeting a TMT business, filed on Monday with the SEC to raise up to $250 million in an initial public offering. The Duluth, GA-based company plans to raise $250 million by offering 25 million units at $10. Each unit consists of
Renaissance Capital

TMT SPAC Spartacus Acquisition files for a $250 million IPO

6 years ago
Spartacus Acquisition, a blank check company targeting a TMT business, filed on Monday with the SEC to raise up to $250 million in an initial public offering. The Duluth, GA-based company plans to raise $250 million by offering 25 million units at $10. Each unit consists of
Renaissance Capital

Renaissance Capital's 3Q 2020 US IPO Market Review

6 years ago
IPO Frenzy Drives Busiest Third Quarter Since 2000 The US IPO market had its busiest third quarter by deal count since the Dot-com era, with 81 IPOs set to raise $28.5 billion. The high volume combined with several large deals resulted in the largest quarter by proceeds in six ye
Renaissance Capital
Checked
5 minutes 51 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed